ACM
EW icon

Aster Capital Management’s Edwards Lifesciences EW Stock Holding History

Aster Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,482
Closed -$107K – 974
2026
Q1 		$107K Buy
+1,482
New +$122K 0.04% 317
2025
Q4 		– Sell
-7,263
Closed -$565K – 1186
2025
Q3 		$565K Buy
7,263
+4,805
+195% +$375K 0.29% 90
2025
Q2 		$192K Buy
+2,458
New +$183K 0.04% 386
2025
Q1 		– Sell
-8,642
Closed -$640K – 1377
2024
Q4 		$640K Buy
8,642
+7,699
+816% +$539K 0.24% 110
2024
Q3 		$62.2K Buy
+943
New +$68.5K 0.01% 453

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aster Capital Management's EW Position: Q2 2026 in Review

Aster Capital Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 1,482 shares — an estimated $107K sold.

Aster Capital Management first reported a position in EW in Q3 2024 and held it in 5 quarters. The position peaked at $640K in Q4 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Aster Capital Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 1,482 Edwards Lifesciences shares in Q2 2026, an estimated $107K.
  • Aster Capital Management first reported a position in Edwards Lifesciences in Q3 2024 and held it in 5 quarters.
  • Aster Capital Management's Edwards Lifesciences position peaked at $640K in Q4 2024.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.